- Home
- GSBC vs TBPH Comparison
GSBC vs TBPH Comparison
Compare GSBC & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSBC
- TBPH
- Stock Information
- Founded
- GSBC 1923
- TBPH 2013
- Country
- GSBC United States
- TBPH United States
- Employees
- GSBC N/A
- TBPH N/A
- Industry
- GSBC Major Banks
- TBPH Biotechnology: Pharmaceutical Preparations
- Sector
- GSBC Finance
- TBPH Health Care
- Exchange
- GSBC Nasdaq
- TBPH Nasdaq
- Market Cap
- GSBC 676.3M
- TBPH 699.0M
- IPO Year
- GSBC N/A
- TBPH N/A
- Fundamental
- Price
- GSBC $62.71
- TBPH $14.30
- Analyst Decision
- GSBC Hold
- TBPH Strong Buy
- Analyst Count
- GSBC 2
- TBPH 4
- Target Price
- GSBC $60.50
- TBPH $23.00
- AVG Volume (30 Days)
- GSBC 33.4K
- TBPH 568.6K
- Earning Date
- GSBC 10-15-2025
- TBPH 11-11-2025
- Dividend Yield
- GSBC 2.55%
- TBPH N/A
- EPS Growth
- GSBC 17.24
- TBPH N/A
- EPS
- GSBC 5.86
- TBPH 0.26
- Revenue
- GSBC $224,299,000.00
- TBPH $77,205,000.00
- Revenue This Year
- GSBC N/A
- TBPH $79.82
- Revenue Next Year
- GSBC N/A
- TBPH N/A
- P/E Ratio
- GSBC $10.71
- TBPH $55.89
- Revenue Growth
- GSBC 4.82
- TBPH 24.49
- 52 Week Low
- GSBC $47.58
- TBPH $7.88
- 52 Week High
- GSBC $68.02
- TBPH $14.55
- Technical
- Relative Strength Index (RSI)
- GSBC 55.27
- TBPH 71.65
- Support Level
- GSBC $62.76
- TBPH $13.47
- Resistance Level
- GSBC $63.81
- TBPH $14.36
- Average True Range (ATR)
- GSBC 0.92
- TBPH 0.42
- MACD
- GSBC -0.10
- TBPH -0.07
- Stochastic Oscillator
- GSBC 16.98
- TBPH 76.85
About GSBC Great Southern Bancorp Inc.
Great Southern Bancorp Inc is a bank holding company. It is principally engaged in the business of originating residential and commercial real estate loans, construction loans, commercial business loans, and consumer loans. The bank provides various services such as Business Banking, Merchant Services, Debit and Credit cards, Online Banking, Mobile Banking, VIP Banking, Overdraft Protection, and various other related services. It operates into a single segment which is Community Banking.
About TBPH Theravance Biopharma Inc.
Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).